Canine Congenital Kidney and Bladder Disease Study Guide
Overview and Clinical Importance
Congenital kidney and bladder diseases represent a significant category of urinary tract disorders in dogs that are present at birth or develop during fetal development. These conditions range from structural anomalies affecting the ureters and bladder to complex disorders of renal development. Understanding these conditions is essential for the NAVLE because they frequently present in young dogs with clinical signs of urinary dysfunction, recurrent infections, or chronic kidney disease. Early recognition and appropriate management can significantly impact patient outcomes.
This study guide covers four major categories of congenital urinary disease: renal dysplasia and polycystic kidney disease (PKD), urachal anomalies (including urachal diverticulum), ectopic ureters, and Fanconi syndrome. Each condition has distinct breed predispositions, clinical presentations, diagnostic approaches, and treatment strategies that are high-yield for board examinations.
Renal Dysplasia
Definition and Pathophysiology
Renal dysplasia is a developmental disorder characterized by abnormal differentiation of renal parenchyma, resulting in disorganized kidney architecture with immature or abnormal nephron structures. The condition involves abnormal metanephric differentiation, leading to immature glomeruli, tubular maldevelopment, and inappropriate tissue structures for the animal's age. Secondary changes commonly develop, including compensatory hypertrophy of functional nephrons, interstitial fibrosis, and tubulointerstitial nephritis.
Breed Predispositions for Renal Dysplasia
Clinical Signs and Presentation
Clinical signs typically appear between 6 months and 2 years of age and are consistent with chronic kidney disease: polyuria and polydipsia (PU/PD), decreased appetite, vomiting, weight loss, lethargy, and halitosis. Dogs with early-onset disease may demonstrate growth stunting (dwarfism). In severe cases, renal secondary osteodystrophy can cause loose teeth, deformable maxilla and mandible, or pathological fractures, though these findings are uncommon and typically occur only in young dogs with end-stage disease.
Diagnostic Findings in Renal Dysplasia
Treatment and Prognosis
There is no curative treatment for renal dysplasia. Management focuses on supportive care for chronic kidney disease: fluid therapy for dehydration, renal diet (protein and phosphorus restriction in later stages), phosphate binders, anti-emetics, potassium supplementation if needed, and management of secondary hypertension and anemia. Prognosis is guarded to poor, with many affected dogs developing end-stage renal disease. Life expectancy varies depending on severity: newborn puppies with severe forms rarely survive beyond 3-6 months, while dogs with moderate disease may live 1-2 years.
Polycystic Kidney Disease (PKD)
Definition and Pathophysiology
Polycystic kidney disease (PKD) is characterized by progressive formation of multiple fluid-filled cysts that gradually replace normal renal parenchyma. The cysts develop from the renal tubules and progressively enlarge over time, eventually compromising kidney function. Unlike renal dysplasia where kidneys are typically small, PKD kidneys are usually enlarged and palpably abnormal. The condition can be inherited as autosomal dominant (Bull Terriers) or autosomal recessive (Cairn Terriers, West Highland White Terriers).
Breed Predispositions and Inheritance Patterns
Clinical Signs and Diagnosis
PKD is often asymptomatic in young dogs. Clinical signs typically emerge in middle-aged dogs when sufficient cyst formation has occurred to impair function. Signs include PU/PD, decreased appetite, weight loss, vomiting, and palpably enlarged kidneys. Cysts may also increase risk of UTIs, causing hematuria and pollakiuria.
Ultrasound is the primary diagnostic tool and can detect cysts as small as 2mm in diameter. Cysts appear as smooth, round or irregular-shaped anechoic (black) structures with distal acoustic enhancement, distributed throughout both cortex and medulla. Unlike renal dysplasia, PKD kidneys are typically larger than normal. Concurrent hepatic or pancreatic cysts may be present, especially in Cairn and WHWT breeds. Genetic testing is available for Bull Terriers (PKD1 gene) and can confirm diagnosis before clinical signs develop.
Treatment and Prognosis
There is no specific treatment for PKD itself. Draining cysts is not practical due to their number and tendency to refill. Management focuses on CKD supportive care: renal diet, fluid supplementation, phosphate binders, and treatment of secondary complications (anemia, hypertension, proteinuria). With appropriate management, many dogs can survive to 8-10 years of age. Prevention requires genetic testing and avoiding breeding affected animals.
Urachal Anomalies
Embryology and Types
The urachus is an embryonic tube connecting the fetal bladder to the allantoic sac through the umbilicus, allowing excretion of fetal urinary waste. Normally, the urachus atrophies and becomes a fibrous cord (median umbilical ligament) before or shortly after birth. Failure of complete urachal closure results in various anomalies depending on which portion remains patent.
Classification of Urachal Anomalies
Clinical Signs
Patent urachus: Continuous urinary incontinence with urine dripping from umbilicus, urine scalding of ventral abdomen, omphalitis, and secondary UTIs. Usually apparent in neonates.
Vesicourachal diverticulum: May be asymptomatic or cause signs of lower urinary tract disease (LUTD) including hematuria, pollakiuria, stranguria, and recurrent bacterial UTIs. Median age at diagnosis is approximately 8.5 years in dogs, though congenital in origin. Dogs with diverticula are often asymptomatic until secondary complications develop.
Diagnosis
Positive contrast cystography is the definitive diagnostic test for urachal anomalies. The contrast outlines the diverticulum as an outpouching at the cranioventral bladder apex. Abdominal ultrasound can identify urachal anomalies in approximately 50% of cases; the anomaly appears as a fluid-filled structure extending cranioventrally from the bladder apex. Cystoscopy provides direct visualization and is highly accurate (diagnosed in 16 of 18 dogs in one study), particularly useful in female dogs.
Treatment
Surgical resection (partial cystectomy) is the treatment of choice for clinically significant urachal anomalies. The apex of the bladder containing the anomaly is excised along with any connections to the umbilicus. Postoperative antimicrobial therapy for 2-4 weeks is indicated when UTI is present. Prognosis following surgery is generally good, with resolution of recurrent UTIs in most cases.
Exam Focus: Memory tip for urachal anomalies: "PUSS" = Patent urachus (urine at umbilicus), Urachal Sinus (humans only), Stasis in diverticulum (recurrent UTI), Surgery fixes it!
Ectopic Ureters
Definition and Pathophysiology
Ectopic ureter is a congenital abnormality in which one or both ureters terminate at an abnormal location distal to the normal trigonal position. Instead of entering the bladder, ectopic ureters may open into the urethra, vagina, vestibule, or uterus in females, or into the urethra (typically distal to the prostate) in males. The condition results from disrupted development of the mesonephric and metanephric duct systems during embryogenesis.
Types of Ectopic Ureters
Epidemiology and Breed Predisposition
Ectopic ureters are much more common in females (female:male ratio approximately 20:1), likely because incontinence is more readily identified in females. Prevalence in dogs is approximately 0.016-0.045%. Unilateral involvement is more common than bilateral (bilateral in approximately 25% of cases). The condition is familial in many breeds.
Predisposed breeds: Labrador Retriever, Siberian Husky, Golden Retriever, Newfoundland, English Bulldog, West Highland White Terrier, Fox Terrier, Skye Terrier, Miniature and Toy Poodles.
Clinical Signs
Urinary incontinence is the hallmark sign, presenting as continuous dribbling or intermittent leaking of urine. Dogs with unilateral ectopic ureters may void normally some of the time, while bilateral involvement typically causes inability to void normally. Additional findings include urine scalding of perivulvar skin, vulvar dermatitis, fur discoloration around genitals, excessive licking of genital area, low-grade vaginitis, and recurrent urinary tract infections.
Concurrent Abnormalities
Approximately 90% of dogs with ectopic ureters have concurrent urinary sphincter mechanism incompetence (USMI), which explains why surgical correction alone may not resolve incontinence. Other associated anomalies include: hydroureter (50% of females, 80% of males), hydronephrosis, renal hypoplasia, bladder hypoplasia, intrapelvic bladder position, short urethra, vaginal septum, and persistent paramesonephric remnant.
Diagnosis
Treatment and Prognosis
Cystoscopic laser ablation (CLA) is the preferred treatment for intramural ectopic ureters (85-90% of cases). A diode laser is used to ablate the tissue forming the medial ectopic ureteral wall, repositioning the orifice into the bladder. Most patients leave hospital within 12-24 hours. Male patients typically achieve continence (approximately 80%), while approximately 50% of females require additional treatment (medications like phenylpropanolamine for USMI, collagen injections, or hydraulic occluder placement).
Surgical neoureterostomy is indicated for extramural ectopic ureters. The ureter is transected and reimplanted into the bladder at a normal location. Complications include stricture formation, uroabdomen, and persistent incontinence.
Fanconi Syndrome
Definition and Pathophysiology
Fanconi syndrome is a generalized proximal renal tubular reabsorptive defect characterized by glucosuria, aminoaciduria, phosphaturia, bicarbonate loss (proximal renal tubular acidosis), and inappropriate urinary excretion of other electrolytes including sodium and potassium. The syndrome results from dysfunction of the proximal convoluted tubule, where normally 60-70% of filtered solutes are reabsorbed. This leads to progressive metabolic acidosis, electrolyte derangements, and eventual renal failure if untreated.
Etiology
Clinical Signs
Polyuria and polydipsia (PU/PD) are the most common presenting signs. Other findings include dehydration, weight loss, weakness, poor coat quality, and muscle wasting. In Basenjis, signs typically emerge between 4-8 years of age, though onset as early as 11 weeks or as late as 10 years has been reported. If untreated, the disease progresses to renal failure with uremic signs (anorexia, vomiting, halitosis, lethargy).
Diagnosis
The pathognomonic finding is glucosuria with normoglycemia or hypoglycemia. This distinguishes Fanconi syndrome from diabetes mellitus, where both blood and urine glucose are elevated. Additional laboratory findings include:
- Metabolic acidosis (low pCO2, low bicarbonate, negative base excess on blood gas)
- Aminoaciduria (detected on urine amino acid analysis)
- Hypokalemia (approximately 1/3 of cases)
- Hypophosphatemia
- Proteinuria
- Negative leptospirosis serology (to rule out infectious cause)
Genetic testing is available for Basenjis through the Veterinary Genetics Laboratory at UC Davis (FAN1 gene mutation). This allows identification of carriers and affected dogs before clinical signs develop. Owners can perform monthly urine glucose screening using standard glucose test strips.
Treatment
Treatment focuses on aggressive replacement of lost solutes and correction of metabolic acidosis. The Gonto Protocol is the standard treatment regimen developed specifically for Basenji Fanconi syndrome:
- Sodium bicarbonate supplementation - dosed based on blood gas analysis to correct acidosis
- High-quality, high-protein diet - to compensate for amino acid losses (differs from typical CKD diet unless concurrent renal failure)
- Potassium supplementation - if hypokalemic
- Vitamin and mineral supplementation - including phosphorus, calcium, vitamin D
- Regular monitoring - frequent blood gas and biochemistry panels initially
For acquired Fanconi syndrome, removal of the underlying cause (e.g., discontinuing chicken jerky treats, treating leptospirosis) may result in improvement or resolution. Labrador Retrievers with copper-associated hepatopathy require copper chelation in addition to the standard protocol.
Prognosis: With early diagnosis and appropriate treatment, affected Basenjis can have near-normal life expectancy. Untreated dogs typically die from complications of progressive renal failure.
Summary: Quick Reference Comparison
Practice NAVLE Questions
Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.
Start Your Free Trial →